04 March 2024
04 March 2024
NE3107 has been investigated in a Phase IIa trial in Parkinson's disease and a Phase III trial in Alzheimer's disease.
The Clinical Trials Arena team evaluates assets in oncology, obesity and dermatology
The STARLIGHT 2 trial is set to assess fezolinetant's superiority compared to placebo, as well as analyse its safety.
The study looked at medical records of more than three million diabetic patients and almost one million non-diabetic patients.
The US Food and Drug Administration (FDA) placed a partial clinical hold on HIV programme and a full hold on Covid-19 trials for CytoDyn’s monoclonal antibody, leronlimab.
The Phase II NIPU trial results of UV1 vaccine in mesothelioma showed positive secondary endpoint outcomes.
Assessing the tolerability and safety of the treatment in hypertensive patients is the trial’s primary goal.
Preclinical data indicated a favourable safety and efficacy profile for Deltacel, especially when used with low-dose radiation.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
